Champions Oncology, Inc.
CSBR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000771856
No open-market purchases or sales by Champions Oncology, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $36.3M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Champions Oncology, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 25 | 28 | +3 |
| Shares | 5.73M | 5.89M | +157.0K (+2.7%) |
| Value | $33.0M | $36.3M | +$3.32M (+10.1%) |
New holders (4)
Institutions that held Champions Oncology, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 18,295 | $112.7K | 0.00% |
| Mercer Global Advisors Inc | 12,775 | $78.7K | 0.00% |
| Barclays PLC | 13 | $80 | 0.00% |
| FMR LLC | 1 | $5 | 0.00% |
Sold out (1)
Institutions that held Champions Oncology, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Dimensional Fund Advisors LP | 23,973 | $137.9K |